← Browse by Condition
Medical Condition

ventricular fibrillation

Total Trials
3
Recruiting Now
3
Trial Phases
Various

ClinicalMetric tracks all active clinical trials for ventricular fibrillation sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.

Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.

Frequently Asked Questions — ventricular fibrillation Clinical Trials

How many clinical trials are currently recruiting for ventricular fibrillation?
ClinicalMetric currently tracks 3 actively recruiting clinical trials for ventricular fibrillation, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 3. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for ventricular fibrillation?
ventricular fibrillation research spans multiple clinical trial phases. Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a ventricular fibrillation clinical trial?
Eligibility criteria for ventricular fibrillation trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Top Sponsors
St. Olavs Hospital 1 trial
Fondazione IRCCS Policlinico San Matteo di Pavia 1 trial
University Hospital of Ferrara 1 trial

Recruiting Clinical Trials

NCT06672159
Recruiting

Initial Double Sequential External Defibrillation in Out of Hospital Cardiac Arrest

Enrollment
356 pts
Location
Norway
Sponsor
St. Olavs Hospital
View Trial →
NCT05720936
Recruiting

In-hospital Stellate Ganglion Block for Arrhythmic Storm

Enrollment
500 pts
Location
Italy, Switzerland
Sponsor
Fondazione IRCCS Policlinico S...
View Trial →
NCT06324682
Recruiting

ConTempoRary Cardiac Stimulation in Clinical practicE: lEft, BivEntriculAr, Right, and conDuction System Pacing

Enrollment
8,400 pts
Location
Italy
Sponsor
University Hospital of Ferrara
View Trial →
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology